In a poignant and urgent appeal to the leaders of the G7, the G20, BRICS, and the broader international community, Brazilian President Luiz Inácio Lula da Silva and World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus have issued a joint call to action. Their message is clear: the world stands at a critical juncture in its effort to ensure that the catastrophic loss of life experienced during the COVID-19 pandemic is never repeated.
Writing from the distinct vantage points of Brasília and Geneva, the two leaders have urged heads of state to break the current deadlock in negotiations regarding the "Pathogen Access and Benefit-Sharing" (PABS) annex. This final, missing piece of the broader WHO Pandemic Agreement is, they argue, the linchpin of a safer global future.
The Weight of Memory: Why the Agreement Matters
The discourse begins not with bureaucratic jargon, but with the visceral memory of the COVID-19 pandemic—a period defined by overflowing hospitals, isolated patients, and the profound grief of millions who lost loved ones. With estimates suggesting that up to 20 million lives were lost to the virus, the world made an implicit promise in the wake of the tragedy: to never again be caught unprepared by a global health emergency.
A little over a year ago, nations took a historic step toward fulfilling that promise by adopting the WHO Pandemic Agreement. This framework was designed to foster cooperation over division, establishing a protocol for how countries can work together to prevent, prepare for, and respond to future biological threats. However, this momentum has stalled. The Agreement cannot enter into force without the finalization of the PABS annex—the mechanism that dictates how nations share information about pathogens and, crucially, how they share the life-saving fruits of that research, such as vaccines and diagnostics.
Chronology of a Stalled Negotiation
The path to a global pandemic accord has been fraught with complex geopolitical and economic hurdles.
- May 1, 2024: Member States concluded their most recent negotiating session. While progress was made in drafting the foundational text, delegates acknowledged that the most contentious issues—specifically the governance and equity mechanisms of the PABS system—remained unresolved.
- The Interim Period: Since May, negotiators have worked behind the scenes to bridge gaps regarding how benefits from shared pathogen data are distributed and how the system remains legally binding yet equitable.
- July 6–17, 2024: This window represents the next, and potentially final, opportunity for negotiators to finalize the annex. The call from Lula and Dr. Tedros is timed precisely to ensure that this session moves beyond technical wrangling and toward a decisive conclusion.
The PABS Annex: Bridging the Gap Between Science and Equity
At the heart of the debate is the Pathogen Access and Benefit-Sharing (PABS) system. The system relies on a "fair bargain": countries that possess samples of emerging, dangerous pathogens must share genetic information and material rapidly so that global scientists can develop the necessary medical countermeasures. In return, the nations that provide these samples must be guaranteed timely and affordable access to the vaccines, tests, and treatments that result from that scientific data.
The Three Pillars of the Appeal
Lula and Dr. Tedros have laid out three specific, actionable requests for world leaders:
1. Political Will at the Highest Level:
The leaders argue that technical negotiators have hit a wall that only heads of government can dismantle. They are calling on leaders to issue clear directives to their delegations: finish the annex as a national priority. Addressing concerns regarding state sovereignty, the authors emphasize that Article 22, paragraph 2 of the Agreement protects national autonomy. The WHO will have no authority to mandate lockdowns, travel restrictions, or vaccination requirements; such powers remain firmly in the hands of sovereign states.
2. A Spirit of Equity:
Equity is not merely a moral imperative, but a strategic one. As Brazil’s G20 presidency noted in 2024, inequality is a primary driver of pandemic severity. By ensuring that vaccines and treatments reach all corners of the globe, the world can contain outbreaks at their source. Furthermore, the PABS system provides "legal certainty." By replacing the current, improvised, case-by-case approach with a stable, predictable framework, laboratories and pharmaceutical partners can operate with the speed required during an emergency.
3. A Sense of Urgency:
The "deadline" for this work is July 17. The authors highlight that the next pandemic is not a matter of "if," but "when." With a one-in-four chance of another pandemic within the next decade, the time for deliberation is rapidly closing. Climate change, evolving agriculture, and advancements in biotechnology have shifted the landscape of risk, making the old assumption that outbreaks only happen in "distant places" obsolete.
Supporting Data: The Economic and Human Toll
The argument for the Agreement is bolstered by staggering financial and human data. The International Monetary Fund (IMF) estimates that the COVID-19 pandemic cost the global economy over $13 trillion in lost output. This economic devastation manifested in shuttered businesses, broken global supply chains, and a lost generation of education for millions of children.
Compared to these figures, the investment required to build a functioning, equitable PABS system is minimal. The current reality, however, is a stark contrast to this goal. As of mid-2024, an Ebola outbreak continues to threaten communities across two nations, with responders working without the benefit of approved vaccines or cures. This is the "distant abstraction" becoming a present danger.
Implications for Global Governance
The successful adoption of the Pandemic Agreement would represent one of the most significant achievements in international health law since the eradication of smallpox. It would signal that the international community is capable of moving past the isolationism that defined the early stages of the COVID-19 crisis.
Strategic Implications
- Containment Efficiency: A coordinated global response is exponentially cheaper and more effective than fragmented national responses.
- Biosecurity: By formalizing the rules for pathogen sharing, the world gains better surveillance, allowing for earlier detection of both natural outbreaks and potential accidental or deliberate releases from biotechnological facilities.
- Institutional Trust: Successful completion of the Agreement would reaffirm the relevance of the WHO and the value of multilateralism in an era of deepening geopolitical rifts.
Conclusion: A Legacy for Future Generations
The letter from President Lula and Dr. Tedros serves as a reminder that the world has stood at such turning points before. From the global effort to end polio to the collective push against HIV, tuberculosis, and malaria, humanity has proven its capacity to unite against biological threats.
"We made a promise to the millions we lost," the leaders wrote. "Let us be the generation that keeps that promise."
As negotiators gather in Geneva for the critical July session, the eyes of the world are fixed on the leaders of the G7, G20, and BRICS. The message from Brasília and Geneva is clear: the technical work is mostly done, but the political finish line remains. The world is watching to see if global leadership will choose the path of solidarity and foresight, or risk the catastrophic consequences of remaining unprepared. The deadline of July 17 is not just a date on a calendar; it is a test of whether the world has truly learned the lessons of the last century’s deadliest health crisis.
About the Author
